The Role of B Cells in Kidney Allograft Dysfunction

Status Completed

Clinical Trial Summary

The purpose of this study is to understand the role of specific B cells in activating or repressing an anti-allograft immune response after kidney transplantation. In this study, blood will be collected from kidney transplant patients during different timepoints, prior to and after their transplant. Knowledge gained from study findings will be used to develop therapeutic strategies to prevent antibody-mediated rejection, which is a major cause of long-term graft loss in kidney transplant patients.

Clinical Trial Description

The purpose of this study is to understand the role of specific B cells in activating or repressing an anti-allograft immune responses after kidney transplantation. This study aims to address two major challenges in kidney transplantation: 1. to guide physicians when immunosuppressive drugs are weaned, and 2. to identify patients who are at risk or in the process of developing antibody-mediated rejection. In this study, blood will be collected from kidney transplant patients during different timepoints, prior to and after their transplant. Knowledge gained from study findings will be used to develop therapeutic strategies to prevent antibody-mediated rejection, which is a major cause of long-term graft loss in kidney transplant patients. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02294032
Study type	Observational [Patient Registry]
Source	Loma Linda University
Contact
Status	Completed
Phase
Start date	August 28, 2014
Completion date	April 24, 2023

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05047406` - Bacillus Clausii in Liver Transplantation	Phase 2
Completed	`NCT02463214` - Prevention of Healthcare Associated Infections in Bone Marrow Transplant Patients	N/A
Recruiting	`NCT05198570` - Pharmacokinetics of Intravenous Acyclovir in Oncologic Paediatric Patients
Completed	`NCT01808456` - Standard-dose Versus High-dose Flu Vaccine in Solid Organ Transplant.	Phase 4
Suspended	`NCT01301118` - Graft Take and Microbiology in Burns	N/A
Completed	`NCT00610961` - Induction Related BK Viremia in Renal Transplant Patients	Phase 4
Recruiting	`NCT05215327` - High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients	Phase 2
Recruiting	`NCT05193058` - Description of Lung Transplant Patients With Microbiologically Documented Stenotrophomonas Maltophilia Pneumonia and Impact of Treatment on Outcome
Unknown status	`NCT01983761` - Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood Transplantation	Phase 1/Phase 2
Active, not recruiting	`NCT02811835` - TransplantLines Food and Nutrition Biobank and Cohort Study (TxL-FN)	N/A
Completed	`NCT01471444` - Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)	Phase 3
Enrolling by invitation	`NCT01349738` - Asymptomatic Bacteriuria & Risk of Urinary Tract Infection in Renal Transplants	N/A
Terminated	`NCT00473824` - Randomized Phase II Study of Hepatitis C Immune Globulin Intravenous (Human), Civacir(TM), in Liver Transplantation	Phase 2
Completed	`NCT00177801` - Organ Transplant Infection Prevention and Detection Project	Phase 4
Completed	`NCT01276457` - Everolimus in Combination With Cyclosporine Microemulsion in de Novo Renal Transplant Recipients	Phase 3
Completed	`NCT02328963` - Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporine Versus an Immunosuppressive Regimen With Mycophenolic Acid and Standard Dose of Cyclosporine A	Phase 4
Recruiting	`NCT04320303` - CMV Infection and Immune Intervention After Transplantation	N/A
Active, not recruiting	`NCT01295645` - Cidofovir Versus Best Supportive Care for Hemorrhagic Cystitis	Phase 2
Completed	`NCT02329808` - Clinical Validation of a Dried Blood Spot Method for Analysis of Immunosuppressives and Antifungals in Pediatrics
Completed	`NCT01471067` - Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies	Phase 1